Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rank in Stocks #27019
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Share Price
$0.16240909
Last synced: 2025-03-04
Market Cap
$35.68M
Change (1 day)
0.27%
Change (1 year)
0.00%
Country
CN
Trade Dali Pharmaceuticalco.,Ltd (603963)

Category

Earnings for Dali Pharmaceuticalco.,Ltd (603963)
Earnings in Sep 2024 TTM: $-3.27M
According to Dali Pharmaceuticalco.,Ltd latest financial reports the company's current earnings are $-3.27M. In 2022 the company made an earning of $-2.46M, an increase over its 2021 earnings that were of $-6.54M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Dali Pharmaceuticalco.,Ltd from 2012 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-3.27M 33.35%
2023 $-2.45M -0.43%
2022 $-2.46M -62.34%
2021 $-6.54M -1,232.14%
2020 $578.00K -76.49%
2019 $2.46M 34.05%
2018 $1.83M -77.19%
2017 $8.04M -23.55%
2016 $10.52M -6.56%
2015 $11.26M -40.72%
2014 $18.99M 6.67%
2013 $17.81M -0.04%
2012 $17.81M 0.00%
Earnings for similar companies or competitors